209 related articles for article (PubMed ID: 27761580)
1. Decreased platelet reactivity in patients with cancer is associated with high risk of venous thromboembolism and poor prognosis.
Riedl J; Kaider A; Marosi C; Prager GW; Eichelberger B; Assinger A; Pabinger I; Panzer S; Ay C
Thromb Haemost; 2017 Jan; 117(1):90-98. PubMed ID: 27761580
[TBL] [Abstract][Full Text] [Related]
2. PO-63 - Exhausted platelets in cancer patients with high risk of venous thromboembolism and poor prognosis.
Riedl J; Kaider A; Marosi C; Prager G; Eichelberger B; Koder S; Panzer S; Pabinger I; Ay C
Thromb Res; 2016 Apr; 140 Suppl 1():S199-200. PubMed ID: 27161749
[TBL] [Abstract][Full Text] [Related]
3. Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS).
Riedl J; Kaider A; Reitter EM; Marosi C; Jäger U; Schwarzinger I; Zielinski C; Pabinger I; Ay C
Thromb Haemost; 2014 Apr; 111(4):670-8. PubMed ID: 24306221
[TBL] [Abstract][Full Text] [Related]
4. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).
Simanek R; Vormittag R; Ay C; Alguel G; Dunkler D; Schwarzinger I; Steger G; Jaeger U; Zielinski C; Pabinger I
J Thromb Haemost; 2010 Jan; 8(1):114-20. PubMed ID: 19889150
[TBL] [Abstract][Full Text] [Related]
5. Platelet Function Decreases with Increasing Severity of Liver Cirrhosis and Portal Hypertension-A Prospective Study.
Brusilovskaya K; Hofer BS; Simbrunner B; Eichelberger B; Lee S; Bauer DJM; Mandorfer M; Schwabl P; Panzer S; Reiberger T; Gremmel T
Thromb Haemost; 2023 Dec; 123(12):1140-1150. PubMed ID: 37517407
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment.
Reitter EM; Kaider A; Ay C; Quehenberger P; Marosi C; Zielinski C; Pabinger I
J Thromb Haemost; 2016 Feb; 14(2):294-305. PubMed ID: 26662117
[TBL] [Abstract][Full Text] [Related]
7. Thrombosis risk and survival in cancer patients with elevated C-reactive protein.
Kanz R; Vukovich T; Vormittag R; Dunkler D; Ay C; Thaler J; Haselböck J; Scheithauer W; Zielinski C; Pabinger I
J Thromb Haemost; 2011 Jan; 9(1):57-63. PubMed ID: 20874781
[TBL] [Abstract][Full Text] [Related]
8. Association of platelet activation markers with cancer-associated venous thromboembolism.
Riedl J; Hell L; Kaider A; Koder S; Marosi C; Zielinski C; Panzer S; Pabinger I; Ay C
Platelets; 2016; 27(1):80-5. PubMed ID: 25970326
[TBL] [Abstract][Full Text] [Related]
9. In Vivo and protease-activated receptor-1-mediated platelet activation in patients presenting for cardiac catheterization.
Gremmel T; Michelson AD; Frelinger AL
Platelets; 2016 Jun; 27(4):308-16. PubMed ID: 26556638
[TBL] [Abstract][Full Text] [Related]
10. Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis.
Brusilovskaya K; Simbrunner B; Lee S; Eichelberger B; Bauer D; Zinober K; Schwabl P; Mandorfer M; Panzer S; Reiberger T; Gremmel T
Platelets; 2022 Aug; 33(6):879-886. PubMed ID: 35294323
[TBL] [Abstract][Full Text] [Related]
11. Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality.
Ay C; Posch F; Kaider A; Zielinski C; Pabinger I
J Thromb Haemost; 2015 Mar; 13(3):390-7. PubMed ID: 25529107
[TBL] [Abstract][Full Text] [Related]
12. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism.
Mrozinska S; Cieslik J; Broniatowska E; Malinowski KP; Undas A
J Thromb Haemost; 2019 Nov; 17(11):1912-1922. PubMed ID: 31323706
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis reveals the high levels of platelet activation parameters in circulation of multiple sclerosis patients.
Morel A; Rywaniak J; Bijak M; Miller E; Niwald M; Saluk J
Mol Cell Biochem; 2017 Jun; 430(1-2):69-80. PubMed ID: 28210898
[TBL] [Abstract][Full Text] [Related]
14. The effect of prasugrel on ADP-stimulated markers of platelet activation in patients with sickle cell disease.
Jakubowski JA; Zhou C; Winters KJ; Lachno DR; Howard J; Payne CD; Mant T; Jurcevic S; Frelinger AL
Platelets; 2015; 26(5):474-9. PubMed ID: 25140584
[TBL] [Abstract][Full Text] [Related]
15. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
[TBL] [Abstract][Full Text] [Related]
16. Obesity is associated with poor response to clopidogrel and an increased susceptibility to protease activated receptor-1 mediated platelet activation.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
Transl Res; 2013 May; 161(5):421-9. PubMed ID: 23340049
[TBL] [Abstract][Full Text] [Related]
17. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).
Ay C; Simanek R; Vormittag R; Dunkler D; Alguel G; Koder S; Kornek G; Marosi C; Wagner O; Zielinski C; Pabinger I
Blood; 2008 Oct; 112(7):2703-8. PubMed ID: 18539899
[TBL] [Abstract][Full Text] [Related]
18. Relationship of Platelet Glycoprotein IIb/IIIa and CD62P With Hypercoagulable State After Oncologic Surgery.
Zhong X; Cao Z; Song J; Liu Y; Guo Q
Clin Appl Thromb Hemost; 2020; 26():1076029620977906. PubMed ID: 33259230
[TBL] [Abstract][Full Text] [Related]
19. Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients.
Königsbrügge O; Posch F; Riedl J; Reitter EM; Zielinski C; Pabinger I; Ay C
Oncologist; 2016 Feb; 21(2):252-7. PubMed ID: 26764252
[TBL] [Abstract][Full Text] [Related]
20. Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty.
Gremmel T; Xhelili E; Steiner S; Koppensteiner R; Kopp CW; Panzer S
Atherosclerosis; 2014 Jan; 232(1):119-24. PubMed ID: 24401225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
